ArticleFrontiers in immunology2022

Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort.

Daniele Mauro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.